Filing Details
- Accession Number:
- 0001209191-15-072348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-28 19:14:16
- Reporting Period:
- 2015-09-25
- Filing Date:
- 2015-09-28
- Accepted Time:
- 2015-09-28 19:14:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311210 | Patrick Clarence Machado | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-25 | 71,980 | $4.69 | 138,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-25 | 11,600 | $40.82 | 125,536 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-25 | 22,236 | $41.63 | 104,300 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-25 | 20,464 | $42.68 | 83,836 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-09-25 | 17,680 | $43.92 | 66,156 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-09-25 | 71,980 | $0.00 | 71,980 | $4.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-10-30 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices between $40.32 and $41.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $41.33 and $42.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $42.34 and $43.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $43.45 and $44.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
